Literature DB >> 8062264

Increased birth weights of National Wilms' Tumor Study patients suggest a growth factor excess.

W M Leisenring1, N E Breslow, I E Evans, J B Beckwith, M J Coppes, P Grundy.   

Abstract

An analysis of over 1800 patients with Wilms' tumor revealed significantly higher birth weights than newborns in the general United States population. The highest birth weights were found not only in patients diagnosed with the Beckwith-Wiedemann syndrome (mean, 3.78 kg), as had been expected, but also in those with hemihypertrophy (3.80 kg) or perilobar nephrogenic rests (3.56 kg) in addition to their Wilms' tumor. The birth weights of Wilms' tumor patients with intralobar nephrogenic rests (3.43 on average kg) and of those without associated anomalies (3.45 kg) were slightly but still significantly higher on average than national birthweights (overall mean, 3.35 kg) adjusted for gender, race, and year of birth in each subgroup. Birth weights of children with aniridia and Wilms' tumor (2.99 kg) were lower than the national mean. Among more than 3000 patients with Wilms' tumor, heights and weights at diagnosis were significantly higher for the subgroups of patients with Beckwith-Wiedemann syndrome or hemihypertrophy, and height was lower for those with aniridia or characteristic genitourinary anomalies, when compared to other patients with Wilms' tumor. These data suggest prenatal effects of growth factors on the development of Wilms' tumors, or vice versa, and provide further epidemiological support for heterogeneity in the pathogenesis of Wilms' tumors associated with perilobar nephrogenic rests versus intralobar nephrogenic rests.

Entities:  

Mesh:

Year:  1994        PMID: 8062264

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

Review 1.  Conditions in utero and cancer risk.

Authors:  Tom Grotmol; Elisabete Weiderpass; Steinar Tretli
Journal:  Eur J Epidemiol       Date:  2006-09-13       Impact factor: 8.082

2.  Cancer risk among children with very low birth weights.

Authors:  Logan G Spector; Susan E Puumala; Susan E Carozza; Eric J Chow; Erin E Fox; Scott Horel; Kimberly J Johnson; Colleen C McLaughlin; Peggy Reynolds; Julie Von Behren; Beth A Mueller
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

3.  Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.

Authors:  A K Charles; K W Brown; P J Berry
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

Review 4.  Big babies and infant leukemia: a role for insulin-like growth factor-1?

Authors:  J A Ross; J P Perentesis; L L Robison; S M Davies
Journal:  Cancer Causes Control       Date:  1996-09       Impact factor: 2.506

Review 5.  Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.

Authors:  R H Scott; C A Stiller; L Walker; N Rahman
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

6.  Height at diagnosis and birth-weight as risk factors for osteosarcoma.

Authors:  Lisa Mirabello; Ruth Pfeiffer; Gwen Murphy; Najat C Daw; Ana Patiño-Garcia; Rebecca J Troisi; Robert N Hoover; Chester Douglass; Joachim Schüz; Alan W Craft; Sharon A Savage
Journal:  Cancer Causes Control       Date:  2011-04-05       Impact factor: 2.506

7.  Anthropomorphic measurements and event-free survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group.

Authors:  Conrad V Fernandez; James Anderson; Norman E Breslow; Jeffrey S Dome; P E Grundy; Elizabeth J Perlman; Daniel M Green
Journal:  Pediatr Blood Cancer       Date:  2009-02       Impact factor: 3.167

8.  Obstetric history and birth characteristics and Wilms tumor: a report from the Children's Oncology Group.

Authors:  Julie L Daniels; I-Jen Pan; Andrew F Olshan; Norman E Breslow; Greta R Bunin; Julie A Ross
Journal:  Cancer Causes Control       Date:  2008-05-29       Impact factor: 2.506

9.  Childhood cancer among twins and higher order multiples.

Authors:  Susan E Puumala; Susan E Carozza; Eric J Chow; Erin E Fox; Scott Horel; Kimberly J Johnson; Colleen McLaughlin; Beth A Mueller; Peggy Reynolds; Julie Von Behren; Logan G Spector
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

10.  Fetal programming and Wilms tumor.

Authors:  Julia E Heck; Di He; Carla Janzen; Noah Federman; Jorn Olsen; Beate Ritz; Johnni Hansen
Journal:  Pediatr Blood Cancer       Date:  2018-09-25       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.